• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predictive accuracy of hormone receptors in conservatively treated endometrial hyperplasia and early endometrioid carcinoma.

作者信息

Raffone Antonio, Travaglino Antonio, Mascolo Massimo, Insabato Luigi, Zullo Fulvio

机构信息

Obstetrics and Gynecology Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.

Anatomic Pathology Unit, Department of Advanced Biomedical Sciences, School of Medicine, University of Naples Federico II, Naples, Italy.

出版信息

Acta Obstet Gynecol Scand. 2020 Jan;99(1):140. doi: 10.1111/aogs.13733. Epub 2019 Oct 8.

DOI:10.1111/aogs.13733
PMID:31529482
Abstract
摘要

相似文献

1
Predictive accuracy of hormone receptors in conservatively treated endometrial hyperplasia and early endometrioid carcinoma.激素受体在保守治疗的子宫内膜增生和早期子宫内膜样癌中的预测准确性。
Acta Obstet Gynecol Scand. 2020 Jan;99(1):140. doi: 10.1111/aogs.13733. Epub 2019 Oct 8.
2
[Hormone receptors and markers in endometrial hyperplasia. Immunohistochemical study].[子宫内膜增生中的激素受体与标志物。免疫组织化学研究]
Rev Med Chir Soc Med Nat Iasi. 2010 Jan-Mar;114(1):180-4.
3
Predictive value of estrogen and progesterone receptors in endometrial hyperplasia and cancer.雌激素和孕激素受体在子宫内膜增生及癌症中的预测价值
Acta Obstet Gynecol Scand. 2020 Jan;99(1):139. doi: 10.1111/aogs.13720. Epub 2019 Sep 12.
4
IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.子宫内膜增生和子宫内膜腺癌中的免疫组织化学
Rev Med Chir Soc Med Nat Iasi. 2016 Apr-Jun;120(2):355-62.
5
Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.FOXO1 mRNA水平下调预示着采用含孕激素宫内节育器保守治疗的子宫内膜病变患者治疗失败。
Gynecol Oncol. 2016 Jan;140(1):152-60. doi: 10.1016/j.ygyno.2015.10.023. Epub 2015 Oct 30.
6
Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.子宫内膜透明细胞癌的特征在于p53、Ki-67、雌激素和孕激素受体表达的独特模式。
Hum Pathol. 1998 Jun;29(6):551-8. doi: 10.1016/s0046-8177(98)80002-6.
7
Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.是否应该评估孕激素和雌激素受体以预测子宫内膜增生和癌症保守治疗的反应？系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2019 Aug;98(8):976-987. doi: 10.1111/aogs.13586. Epub 2019 Mar 28.
8
Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction.D评分阴性的高危子宫内膜增生中共存癌的预后标志物：形态计量学、激素受体和细胞凋亡对结局预测的意义
Acta Obstet Gynecol Scand. 2009;88(11):1234-42. doi: 10.3109/00016340903281014.
9
Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.肿瘤相关巨噬细胞与子宫内膜样腺癌中孕激素受体缺失相关。
J Obstet Gynaecol Res. 2013 Apr;39(4):855-63. doi: 10.1111/j.1447-0756.2012.02036.x. Epub 2012 Oct 29.
10
Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.子宫内膜单纯性增生和子宫内膜样癌中的雌激素受体β（ERβ）
Appl Immunohistochem Mol Morphol. 2008 Dec;16(6):535-42. doi: 10.1097/PAI.0b013e31816755a9.

引用本文的文献

1
Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions.非典型子宫内膜增生和子宫内膜癌患者的保留生育力方法：当前证据和未来方向。
Int J Mol Sci. 2022 Feb 25;23(5):2531. doi: 10.3390/ijms23052531.
2
Hysteroscopy in the management of endometrial hyperplasia and cancer in reproductive aged women: new developments and current perspectives.宫腔镜检查在育龄期妇女子宫内膜增生和癌症管理中的应用：新进展与当前观点
Transl Cancer Res. 2020 Dec;9(12):7767-7777. doi: 10.21037/tcr-20-2092.
3
Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol.
非典型子宫内膜增生和子宫内膜癌的保留生育功能治疗：Cochrane系统评价方案
Adv Ther. 2021 May;38(5):2717-2731. doi: 10.1007/s12325-021-01693-y. Epub 2021 Apr 8.
4
Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.子宫内膜癌组织学类型对 TCGA 分子亚群预后价值的影响。
Arch Gynecol Obstet. 2020 Jun;301(6):1355-1363. doi: 10.1007/s00404-020-05542-1. Epub 2020 Apr 15.